FDA Commissioner Andrew von Eschenbach has written Congress a letter asking for $275 million in increased funding for the agency, according to an article in the International Herald Tribune. Bowing to pressure from both Democrats and Republicans, the money will allow the opening of new foreign offices, increased inspections, and the construction of new databases to track drug hazards. "In 30 years at the agency, I never saw anything like this happen before," said William Hubbard, a former deputy FDA commissioner.
Maybe It'll Let Them Pay Attention to Consumer Genomics
May 15, 2008